H.R.2505: Human Cloning Prohibition Act of 2001

Referred to the House Committee on the Judiciary.

Referred to the Subcommittee on Crime.

Subcommittee Consideration and Mark-up Session Held.

Forwarded by Subcommittee to Full Committee by Voice Vote.

Committee Consideration and Mark-up Session Held.

Ordered to be Reported by the Yeas and Nays: 18 - 11.

Mr. Armey asked unanimous consent that the Committee on Judiciary have until 5:00 p.m. on July 28 to file a report on H.R. 2505. Agreed to without objection.

Reported (Amended) by the Committee on Judiciary. H. Rept. 107-170.

Placed on the Union Calendar, Calendar No. 101.

Rules Committee Resolution H. Res. 214 Reported to House. Rule provides for consideration of H.R. 2505 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.

Rule H. Res. 214 passed House.

Considered under the provisions of rule H. Res. 214.

Rule provides for consideration of H.R. 2505 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.

DEBATE - The House proceeded with one hour of debate on H.R. 2505.

DEBATE - Pursuant to the provisions of H. Res. 214, the House proceeded with 10 minutes of debate on the Scott amendment.

DEBATE - Pursuant to the provisions of H. Res. 214, the House proceeded with one hour of debate on the Greenwood amendment in the nature of a substitute.

Ms. Lofgren moved to recommit with instructions to Judiciary.

Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Lofgren motion to recommit with instructions. The instructions contained in the motion require the bill to be reported back to the House with an amendment to provide that nothing in the bill shall prohibit the use of human somatic cell nuclear transfer in connection with the development or application of treatments designed to address Parkinson's disease, Alzheimer's disease, diabetes, cancer, heart disease, spinal cord injury, multiple sclerosis, severe burns, or other diseases, disorders, or conditions, provided that the product of such use is not utilized to initiate a pregnancy and is not intended to be utilized to initiate a pregnancy and that nothing in the bill shall exempt any product from any applicable regulatory approval.

The previous question on the motion to recommit with instructions was ordered without objection.

On motion to recommit with instructions Failed by recorded vote: 175 - 251 (Roll no. 303).

On passage Passed by recorded vote: 265 - 162 (Roll no. 304).

Motion to reconsider laid on the table Agreed to without objection.

Received in the Senate.

Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 140.